Improving Patient Safety In Radiation Therapy With The Watchdog Real-time Treatment Delivery Verification System
Funder
National Health and Medical Research Council
Funding Amount
$593,742.00
Summary
Radiation therapy is a highly effective cancer treatment with extremely high doses delivered using very complex treatment machines. Unfortunately errors have occurred resulting in cases of patient death and mistreatment. We have developed a novel method to assess the treatment delivery in real-time to prevent errors. The method uses imaging devices that are already present on the treatment machine meaning that this method could have a major impact on patient safety in modern radiation therapy.
Biofocussed Prostate Cancer RadioTherapy (BiRT): A Personalised Approach To Delivering The Right Dose To The Right Place
Funder
National Health and Medical Research Council
Funding Amount
$753,565.00
Summary
We propose a new approach to treating prostate cancer with radiotherapy to move from the standard whole prostate treatment to a personalised treatment that varies radiation intensity throughout the prostate. We will mathematically combine features that influence radiotherapy effect from advanced imaging, clinical and biopsy information. This model will map out the radiotherapy dose required at each part of the prostate, to maximise killing of the cancer whilst minimising harm to normal tissue
Non-invasive Near-infrared Optical Imaging Of Neurodegeneration
Funder
National Health and Medical Research Council
Funding Amount
$312,033.00
Summary
Dementia currently affects over 240,000 Australians with an increasing health cost. A common cause of dementia occurs when proteins in the brain form deposits and brain cells degenerate and die. This project will develop a novel medical imaging method that will facilitate the detection of dying brain cells. This will enable a better understanding of the causes of cell death and the opportunity to identify the best time for meaningful therapeutic intervention.
Micro-elastography - A New Tool For Microscopic Intraoperative Tumour Margin Assessment In Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$195,956.00
Summary
In breast cancer surgery, it is vital to completely remove the entire tumour. Unfortunately, in 30% of breast-conserving surgeries, re-excision is required because microscopic analysis after the surgery indicated some tumour had been missed. This has traumatic consequences for the patient and places a huge economic burden on the healthcare system. Using micro-elastography, we will enable the surgeon to detect small regions of tumour during the initial surgery. This probe may significantly reduce ....In breast cancer surgery, it is vital to completely remove the entire tumour. Unfortunately, in 30% of breast-conserving surgeries, re-excision is required because microscopic analysis after the surgery indicated some tumour had been missed. This has traumatic consequences for the patient and places a huge economic burden on the healthcare system. Using micro-elastography, we will enable the surgeon to detect small regions of tumour during the initial surgery. This probe may significantly reduce the number of additional surgeries required.Read moreRead less
We have previously made the most widely used animal brain atlas in the world. This atlas based on stained histological sections of the rat brain. In recent years, advances in MRI have made it possible to generate images of the rat brain at very high resolution. We have obtained a very high quality MRI image set from colleagues in Duke University in the USA, and we have begun to map these images in great detail, using our histological atlas as a guide.
Optimising Radiation Therapy Delivery For Cancer Patients Using Daily Image Guidance To Maximize Cure And Reduce Normal Tissue Side Effects
Funder
National Health and Medical Research Council
Funding Amount
$510,968.00
Summary
When using radiotherapy to kill tumours, the radiation beams need to be targeted at the tumour, plus a margin of error around it to ensure that it receives sufficient dose despite uncertainties in its exact location relative to reference points used for beam alignment. Advanced statistical modelling techniques applied to data collected from patients will be used to determine the optimal margin width for individual patients to maximise cancer cure while minimising normal tissue side effects.
Novel Nanomaterial Solutions Based On Metal And Metal Oxide For Advanced Diagnosis Of Cardiovascular Diseases
Funder
National Health and Medical Research Council
Funding Amount
$581,037.00
Summary
Cardiovascular disease accounts of over one third of all deaths in Australia and is forecasted to become the leading cause of death in Australia and worldwide. Currently, atherosclerosis and thrombosis in coronary arteries are diagnosed by X-ray angiography, an invasive and risk-associated procedure. Our project will explore new contrast agents for the fast, reliable and safe diagnosis of cardiovascular diseases and thrombotic events, which is beneficial to many patients.
Brainstem And Hypothalamic Function And Anatomy In Migraine
Funder
National Health and Medical Research Council
Funding Amount
$652,828.00
Summary
Migraine is a disabling condition characterized by mostly unilateral throbbing head pain and a range of associated neurological symptoms. The underlying mechanisms responsible for the initiation of migraine remains unknown. We aim to determine brain anatomy and activity patterns in migraineurs throughout the migraine cycle. An understanding of the mechanisms responsible for migraine will aid in better treatment development.
EXTEND-IA Randomized Trial Of Intra-arterial Clot Retrieval In Ischemic Stroke
Funder
National Health and Medical Research Council
Funding Amount
$764,534.00
Summary
Most strokes are caused by a blocked blood vessel in the brain. Current treatments to dissolve the blockage improve recovery for many patients but often fail to unblock larger brain arteries. The EXTEND-IA trial will use advanced brain imaging to identify patients who have the most to gain if the blocked artery can be re-opened. The trial will test whether a new minimally invasive clot removal procedure performed after standard clot-dissolving treatment improves recovery after stroke.
The Development Of Innovative Multiplexed Molecular Imaging Technology Targeting Improved Diagnostic Imaging Of Glioblastoma Multiforme
Funder
National Health and Medical Research Council
Funding Amount
$403,599.00
Summary
Glioblastoma Multiforme (GBM) is extremely invasive and the most lethal of all primary brain tumours. To optimise treatment planning, we propose to develop novel Multiplexed Molecular Imaging (MMI) technology employing the latest PET-MRI hybrid imaging technology. Our strategy targets the development of new F19 MRI MI agents for measuring tumour infiltration that can be multiplexed with F18 PET hypoxia tracers. Our MI agents can also act as conjugative vehicles for drug delivery.